Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:02221892n
Noun Named Entity
EL
No term available
EN
Sipuleucel-T, sold under the brand name Provenge, developed by Dendreon Pharmaceuticals, LLC, is a cell-based cancer immunotherapy for prostate cancer. Wikipedia
Relations
Sources
IS A
χημική ουσία
χημική ένωση
φάρμακο
ανοσοδιεγέρτη

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License